» Articles » PMID: 20805791

Role of Extracellular Membrane Vesicles in the Pathogenesis of Various Diseases, Including Cancer, Renal Diseases, Atherosclerosis, and Arthritis

Overview
Journal Lab Invest
Specialty Pathology
Date 2010 Sep 1
PMID 20805791
Citations 98
Authors
Affiliations
Soon will be listed here.
Abstract

Extracellular membrane vesicles (MVs) 30-1000 nm in diameter and of varying cellular origins are increasingly recognized for their participation in a range of processes, including the pathogenesis of various diseases, such as: (1) atherosclerosis, (2) thromboembolism, (3) osteoarthritis (OA), (4) chronic renal disease and pulmonary hypertension, (5) tissue invasion and metastasis by cancer cells, (6) gastric ulcers and bacterial infections, and (7) periodontitis. MVs are derived from many different cell types and intracellular mechanisms, and perform different metabolic functions or roles, depending on the cell of origin.The presence of a metabolically active, outer membrane is a distinguishing feature of all MVs, regardless of their cell type of origin and irrespective of terminologies applied to them such as exosomes, microparticles, or matrix vesicles. The MV membrane provides one of the few protected and controlled internal microenvironments outside cells in which specific metabolic objectives of the host cell may be pursued vigorously at a distance from the host cell. MVs are also involved in various forms of normal and abnormal intercellular communication. Evidence is emerging that circulating MVs are good predictors of the severity of several diseases. In addition, recently, the role of MVs in inducing immunity against cancer cells and bacterial infections has become a topic of interest to researchers in the area of therapeutics. The main objective of this review is to list and briefly describe the increasingly well-defined roles of MVs in selected diseases in which they seem to have a significant role in pathogenesis.

Citing Articles

Trypanosomatid Extracellular Vesicles as Potential Immunogens for Chagas Disease.

Aggio J, Vedam V, Nisimura L, da Silva R, Lovo-Martins M, Borges B Int J Mol Sci. 2025; 26(4).

PMID: 40004010 PMC: 11855489. DOI: 10.3390/ijms26041544.


Innovative Strategies in Oncology: Bacterial Membrane Vesicle-Based Drug Delivery Systems for Cancer Diagnosis and Therapy.

Li G, Pu S, You L, Gao Y, Zhong Y, Zhao H Pharmaceutics. 2025; 17(1).

PMID: 39861706 PMC: 11768367. DOI: 10.3390/pharmaceutics17010058.


Bibliometric analysis of research on osteoarthritis and extracellular vesicles: Trends and frontiers.

Ding Y, Liang L, Guo Y, Zhu B Heliyon. 2024; 10(16):e36127.

PMID: 39224260 PMC: 11366935. DOI: 10.1016/j.heliyon.2024.e36127.


miR-1246 promotes osteosarcoma cell migration via NamiRNA-enhancer network dependent on Argonaute 2.

Yang S, Zou Q, Liang Y, Zhang D, Peng L, Li W MedComm (2020). 2024; 5(4):e543.

PMID: 38585233 PMC: 10999177. DOI: 10.1002/mco2.543.


Klf10 is involved in extracellular matrix calcification of chondrocytes alleviating chondrocyte senescence.

Peng R, Shang J, Jiang N, Chi-Jen H, Gu Y, Xing B J Transl Med. 2024; 22(1):52.

PMID: 38217021 PMC: 10790269. DOI: 10.1186/s12967-023-04666-7.